CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹3.91 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹3.89 Cr |
What is the latest Contingent Liabilities ratio of CONCORD BIOTECH ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹3.91 Cr |
Mar2024 | ₹14 Cr |
Mar2023 | ₹14 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹3.89 Cr |
How is Contingent Liabilities of CONCORD BIOTECH Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3.91 Cr | -72.67 | |
Mar2024 | ₹14 Cr | 0.00 | |
Mar2023 | ₹14 Cr | 7.43 | |
Mar2022 | ₹13 Cr | 242.57 | |
Mar2021 | ₹3.89 Cr | - |
Compare Contingent Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹16,037.3 Cr | -2.1% | -6.3% | -21% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,872.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,706.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹127,449.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,125.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,827.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -2.1% |
-6.3% |
-21% |
SENSEX | 1.8% |
1.9% |
2.4% |
You may also like the below Video Courses